Aug, 2018
Neuroprotective Effects of Tocovid Pretreatment in a Mouse Stroke Model.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
- Volume
- 27
- Number
- 8
- First page
- 2166
- Last page
- 2174
- Language
- English
- Publishing type
- Research paper (scientific journal)
- DOI
- 10.1016/j.jstrokecerebrovasdis.2018.03.014
BACKGROUND: Tocovid is a new combination of tocotrienols and tocopherol, both of which are neuroprotective agents for preventing cerebral infarction in mice. However, the effects of tocovid on anti-inflammation in ischemic model remain elusive. In the present study, we assessed the effects of Tocovid pretreatment on anti-inflammatory effects after transient middle cerebral occlusion (tMCAO) in mice. MATERIALS AND METHODS: We evaluated the therapeutic and anti-inflammatory effects of tocovid pretreatment (200 mg/kg per day, for 1 month) on mice brain under 60 minutes of tMCAO. The expressive changes of inflammatory markers were observed after tMCAO in mice. RESULTS: Tocovid pretreatment greatly improved the mice neurobehaviors, reduced infarct volumes and decreased expressions of inflammatory markers such as tumor necrosis factor-α (TNF-α), monocyte chemotactic protein-1 (MCP-1) and ionized calcium binding adapter molecule-1 (Iba-1), and improved the damage of neurovascular units including matrix metallopeptidase 9, IgG and collagen IV after tMCAO. CONCLUSIONS: Our present findings demonstrated that oral tocovid pretreatment showed obviously neuroprotective and at least in part by anti-inflammatory effects in ischemic mice brain.
- Link information
- ID information
-
- DOI : 10.1016/j.jstrokecerebrovasdis.2018.03.014
- Pubmed ID : 29803600